Perspective Therapeutics, Inc. — Director's Dealing 2022

Jul 28, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Isoray, Inc. (ISR)
CIK: 0000728387
Period of Report: 2022-07-21

Reporting Person: Hunt Jonathan Robert (Chief Financial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-07-21	Stock Options (right to buy)	$0.33	A	475000	Acquired	2032-07-21	Common Stock (475000)	Direct

Footnotes

F1: 25% vested as of 7/21/2022, and the remaining 75% will vest over the next three (3) years, commencing on 7/21/2023, until fully vested.